Professor Anne Tybjærg-Hansen, MD, DMSc

Chief Physician at the Department of Clinical Biochemistry at Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark (1999). Clinical Professor of Clinical Biochemistry with Focus on Translational Molecular Cardiology at the Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark (2009).

Graduated as medical doctor from the University of Copenhagen in 1981. Board certified as a specialist in Clinical Biochemistry 1996. Scientific education included 1 year at the University of Copenhagen and the Lipid Clinic at Righospitalet, Copenhagen University Hospital. Three years at Hagedorn Research Laboratory, Gentofte, Denmark, and 3 years (87-89) at British Heart Foundation’s Molecular Biology Research Group, London, UK.

Professor Tybjærg-Hansen’s research has focused on the genetics and genomics of cardiovascular disease and related diseases in large prospective studies of the general population (>150.000 participants). Recent focus areas include Mendelian randomization, polygenic risk scores for dyslipidemia and CAD, and amyloidosis and amyloidosis-related heart disease and other diseases.

Professor Tybjærg-Hansen is a current member of the steering committees of the Copenhagen City Heart Study and the Copenhagen General Population Study; and Executive Editor for European Heart Journal from September 2020-, and on the Advisory Board of Nature Reviews in Cardiology from 2024.

Honors include: 2017: Honorary member, Czeck Atherosclerosis Society. 2018: EAS Anitschkow Prize, EAS Scientific Sessions, Lisbon, Portugal. 2018: JLR Distinguished Lecture, ISA Toronto, Canada. 2018: Albert Latner Memorial Lecture, Univ. of Newcastle, UK. 2018: The KFJ Prize, University of Copenhagen, Denmark. 2021: National Lipid Association (NLA) USA, Honorary Lifetime Membership Award. 2023: Family Heart Pioneer Award, Family Heart Foundation Global Summit, Washington DC, USA.